Lescol Xl (Fluvastatin Sodium)

Fluvastatin works by competitively inhibiting the enzyme HMG‑CoA reductase, which is essential for the synthesis of cholesterol in the liver. This inhibition reduces hepatic cholesterol production, leading to an increase in LDL‑receptor expression on liver cells and enhanced removal of LDL cholesterol from the bloodstream.

The appropriate dose of Lescol XL is determined by the prescribing clinician based on the individual’s lipid profile, cardiovascular risk, and tolerance. Dosage may be initiated at a low dose and titrated upward as needed, but the exact regimen should always follow the prescriber’s instructions.

Safety of Lescol XL in pregnancy and lactation has not been definitively established. It should generally be avoided unless the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Lescol XL, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The team then replies with pricing, availability, shipping details and any necessary import documentation.

Lescol XL (fluvastatin) is a moderate‑intensity statin with a relatively favorable safety profile, especially regarding drug‑drug interactions mediated by CYP3A4. Compared with higher‑intensity statins such as atorvastatin or rosuvastatin, fluvastatin may achieve slightly lower LDL‑cholesterol reductions but is often chosen for patients who require a gentler approach or have specific interaction concerns.

Lescol XL tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Lescol XL is taken orally, usually once daily, with or without food, as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water and not split, crushed, or chewed, to preserve its extended‑release formulation.

The most serious adverse events associated with Lescol XL include rhabdomyolysis (severe muscle breakdown that can lead to kidney injury), significant elevations in liver enzymes indicating possible hepatotoxicity, and rare allergic reactions such as angioedema or anaphylaxis. Patients should promptly report unexplained muscle pain, weakness, dark urine, or signs of liver dysfunction.

Lescol XL should be avoided in individuals with active liver disease, unexplained persistent elevations of hepatic transaminases, known hypersensitivity to fluvastatin or any tablet components, and in patients taking contraindicated medications such as strong CYP3A4 inhibitors. Caution is also advised for those with severe renal impairment or a history of statin‑related muscle disorders.